191 related articles for article (PubMed ID: 2022302)
1. In vivo insulin resistance induced by amylin primarily through inhibition of insulin-stimulated glycogen synthesis in skeletal muscle.
Frontoni S; Choi SB; Banduch D; Rossetti L
Diabetes; 1991 May; 40(5):568-73. PubMed ID: 2022302
[TBL] [Abstract][Full Text] [Related]
2. Mechanism by which calcitonin gene-related peptide antagonizes insulin action in vivo.
Choi SB; Frontoni S; Rossetti L
Am J Physiol; 1991 Feb; 260(2 Pt 1):E321-5. PubMed ID: 1996634
[TBL] [Abstract][Full Text] [Related]
3. Amylin-induced in vivo insulin resistance in conscious rats: the liver is more sensitive to amylin than peripheral tissues.
Koopmans SJ; van Mansfeld AD; Jansz HS; Krans HM; Radder JK; Frölich M; de Boer SF; Kreutter DK; Andrews GC; Maassen JA
Diabetologia; 1991 Apr; 34(4):218-24. PubMed ID: 2065857
[TBL] [Abstract][Full Text] [Related]
4. Lack of acute effect of amylin (islet associated polypeptide) on insulin sensitivity during hyperinsulinaemic euglycaemic clamp in humans.
Wilding JP; Khandan-Nia N; Bennet WM; Gilbey SG; Beacham J; Ghatei MA; Bloom SR
Diabetologia; 1994 Feb; 37(2):166-9. PubMed ID: 8163050
[TBL] [Abstract][Full Text] [Related]
5. Effects of islet amyloid polypeptide on hepatic insulin resistance and glucose production in the isolated perfused rat liver.
Roden M; Liener K; Fürnsinn C; Nowotny P; Hollenstein U; Vierhapper H; Waldhäusl W
Diabetologia; 1992 Feb; 35(2):116-20. PubMed ID: 1312493
[TBL] [Abstract][Full Text] [Related]
6. Rat amylin-(8-37) enhances insulin action and alters lipid metabolism in normal and insulin-resistant rats.
Hettiarachchi M; Chalkley S; Furler SM; Choong YS; Heller M; Cooper GJ; Kraegen EW
Am J Physiol; 1997 Nov; 273(5):E859-67. PubMed ID: 9374670
[TBL] [Abstract][Full Text] [Related]
7. Metabolic effects of IGF-I in diabetic rats.
Rossetti L; Frontoni S; Dimarchi R; DeFronzo RA; Giaccari A
Diabetes; 1991 Apr; 40(4):444-8. PubMed ID: 2010044
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor-I inhibits insulin and amylin secretion in conscious rats.
Fürnsinn C; Alma M; Roden M; Pieber T; Nowotny P; Schneider B; Waldhäusl W
Endocrinology; 1994 Nov; 135(5):2144-9. PubMed ID: 7956938
[TBL] [Abstract][Full Text] [Related]
9. Amylin-mediated reduction in insulin sensitivity corresponds to reduced insulin receptor kinase activity in the rat in vivo.
Bryer-Ash M; Follett L; Hodges N; Wimalawansa S
Metabolism; 1995 Jun; 44(6):705-11. PubMed ID: 7783653
[TBL] [Abstract][Full Text] [Related]
10. Islet amyloid polypeptide inhibits insulin secretion in conscious rats.
Fürnsinn C; Leuvenink H; Roden M; Nowotny P; Schneider B; Rohac M; Pieber T; Clodi M; Waldhäusl W
Am J Physiol; 1994 Aug; 267(2 Pt 1):E300-5. PubMed ID: 8074211
[TBL] [Abstract][Full Text] [Related]
11. Prolonged suppression of glucose metabolism causes insulin resistance in rat skeletal muscle.
Kim JK; Youn JH
Am J Physiol; 1997 Feb; 272(2 Pt 1):E288-96. PubMed ID: 9124337
[TBL] [Abstract][Full Text] [Related]
12. Increased hexosamine availability similarly impairs the action of insulin and IGF-1 on glucose disposal.
Hawkins M; Barzilai N; Chen W; Angelov I; Hu M; Cohen P; Rossetti L
Diabetes; 1996 Dec; 45(12):1734-43. PubMed ID: 8922359
[TBL] [Abstract][Full Text] [Related]
13. Hyperamylinemia is associated with hyperinsulinemia in the glucose-tolerant, insulin-resistant offspring of two Mexican-American non-insulin-dependent diabetic parents.
Gulli G; Rossetti L; DeFronzo RA
Metabolism; 1997 Oct; 46(10):1157-61. PubMed ID: 9322799
[TBL] [Abstract][Full Text] [Related]
14. Multiple metabolic effects of CGRP in conscious rats: role of glycogen synthase and phosphorylase.
Rossetti L; Farrace S; Choi SB; Giaccari A; Sloan L; Frontoni S; Katz MS
Am J Physiol; 1993 Jan; 264(1 Pt 1):E1-10. PubMed ID: 8430777
[TBL] [Abstract][Full Text] [Related]
15. The effects of amylin on carbohydrate metabolism in skeletal muscle in vitro and in vivo.
Leighton B; Foot E
Biochem J; 1990 Jul; 269(1):19-23. PubMed ID: 2198023
[TBL] [Abstract][Full Text] [Related]
16. Acute effects of the human amylin analog AC137 on basal and insulin-stimulated euglycemic and hypoglycemic fuel metabolism in patients with insulin-dependent diabetes mellitus.
Nyholm B; Møller N; Gravholt CH; Orskov L; Mengel A; Bryan G; Moyses C; Alberti KG; Schmitz O
J Clin Endocrinol Metab; 1996 Mar; 81(3):1083-9. PubMed ID: 8772580
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance caused by amylin in conscious rats is independent of induced hypocalcemia and fades during long-term exposure.
Fürnsinn C; Nowotny P; Roden M; Rohac M; Pieber T; Parzer S; Waldhäusl W
Acta Endocrinol (Copenh); 1993 Oct; 129(4):360-5. PubMed ID: 8237256
[TBL] [Abstract][Full Text] [Related]
18. Effects of amylin on glucose metabolism and glycogenolysis in vivo and in vitro.
Young DA; Deems RO; Deacon RW; McIntosh RH; Foley JE
Am J Physiol; 1990 Sep; 259(3 Pt 1):E457-61. PubMed ID: 2399978
[TBL] [Abstract][Full Text] [Related]
19. Amylin and amylin-amide lack an acute effect on blood glucose and insulin.
Ghatei MA; Datta HK; Zaidi M; Bretherton-Watt D; Wimalawansa SJ; MacIntyre I; Bloom SR
J Endocrinol; 1990 Feb; 124(2):R9-11. PubMed ID: 2179452
[TBL] [Abstract][Full Text] [Related]
20. Amylin and CGRP induce insulin resistance via a receptor distinct from cAMP-coupled CGRP receptor.
Kreutter DK; Orena SJ; Torchia AJ; Contillo LG; Andrews GC; Stevenson RW
Am J Physiol; 1993 Apr; 264(4 Pt 1):E606-13. PubMed ID: 8386456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
